Stock listing

MRNA Stock Price, News, Filings & Events — Moderna, Inc.

Selected listing: MRNA · NASDAQ · USD · US

MRNA:NASDAQ is the primary listing for Moderna, Inc., a biotechnology company focused on mRNA-based therapeutics and vaccines. With a market capitalization of around $24.53 billion, Moderna continues to be a key player in the biotech industry, especially in the context of vaccine development. Recent news and filings highlight the company's ongoing research and advancements in mRNA technology, reflecting its commitment to innovation in healthcare.

MRNA:NASDAQUSDUSUpdated July 21, 2026
Moderna, Inc. logo
Ticker
MRNA:NASDAQ
Asset type
Stock
Market cap
$24.53B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Moderna, Inc. MRNA:NASDAQ stock context

MRNA:NASDAQ is the primary listing for Moderna, Inc., a biotechnology company focused on mRNA-based therapeutics and vaccines. With a market capitalization of around $24.53 billion, Moderna continues to be a key player in the biotech industry, especially in the context of vaccine development. Recent news and filings highlight the company's ongoing research and advancements in mRNA technology, reflecting its commitment to innovation in healthcare.

Research Moderna, Inc.

Alternate listings